Retinal Degenerative Diseases XIX

Retinal Degenerative Diseases XIX

6 $

Format : Publisher PDF

File Size : 32.1 MB

Category:

Retinal Degenerative Diseases XIX

by John Ash (Author)

Introducing the latest publication in the field of retinal degenerations – “Proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018)” edited by John Ash. This book features a collection of state-of-the-art research presented at the symposium, delving into various aspects of retinal degenerations and exploring potential therapeutic measures such as gene therapy and neuroprotective agents. It is a must-have for researchers, clinicians, and anyone interested in advancing knowledge and finding solutions for retinal degenerative diseases.

The blinding diseases of inherited retinal degenerations affect countless individuals worldwide, with age-related macular degeneration alone impacting 1 in 3-4 individuals aged 70 and above. Unfortunately, there are no current treatments for these diseases. The RD Symposium, renowned as one of the most important gatherings in the field, brought together leading scientists and experts to shed light on the latest developments and potential therapies.

The symposium covered a wide range of topics including cytopathologic, physiologic, diagnostic, and clinical aspects of retinal degenerations. Researchers discussed animal models, mechanisms of cell death, molecular genetics, and cutting-edge therapeutic approaches like gene therapy and neuroprotective agents. The volume serves as a comprehensive overview of these topics, showcasing the current state of research in the field.

While the book encompasses the latest advancements, it also highlights emerging areas of study that were not explored in previous symposiums. These include the role of inflammation and immunity in age-related macular degeneration, gene therapy breakthroughs, and revolutionary imaging and functional testing techniques that have the potential to revolutionize the field.

One of the most significant aspects of this volume is the focus on neuroprotective and gene therapy. The retina, being part of the central nervous system, offers unique opportunities for developing therapies for neurodegenerative diseases. Exciting clinical trials, including restoring sight in blind children, have already shown promising results in retinal degeneration therapies. The successes shared at previous RD Symposia have led to collaborative efforts and breakthroughs that are featured in the current volume.

Readers can anticipate a wealth of information and groundbreaking research that reflects the enthusiasm and dedication of those working in the field of retinal degenerations. The volume not only provides valuable insights but also stimulates new ideas and avenues for research. Whether you are a researcher, clinician, or someone affected by retinal degenerations, this book is an essential resource that will deepen your understanding and inspire you to contribute to finding new therapeutic measures for these debilitating diseases.

Product Details

  • Publisher: Springer International Publishing; September 2, 2023
  • Language: English
  • ISBN: 9783031276804
  • ISBN: 9783031276811

Order your copy of “Proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018)” today and delve into the latest research and advancements in the field of retinal degenerations. Gain valuable insights into the mechanisms of these diseases, explore potential therapeutic measures, and be inspired by the collaborative efforts of leading scientists and experts in the field.

By ordering this book, you are taking a step towards deepening your knowledge of retinal degenerative diseases and contributing to the ongoing pursuit of effective treatments and cures. Don’t miss out on this invaluable resource – place your order now and join the quest to combat retinal degenerations.

Can’t wait to explore the contents of the book? Check out the video below for a sneak peek into the symposium and the exciting research presented:

Related Products